ZA200206252B - Method and compositions for treating an inflammatory disease. - Google Patents

Method and compositions for treating an inflammatory disease.

Info

Publication number
ZA200206252B
ZA200206252B ZA200206252A ZA200206252A ZA200206252B ZA 200206252 B ZA200206252 B ZA 200206252B ZA 200206252 A ZA200206252 A ZA 200206252A ZA 200206252 A ZA200206252 A ZA 200206252A ZA 200206252 B ZA200206252 B ZA 200206252B
Authority
ZA
South Africa
Prior art keywords
compositions
treating
inflammatory disease
inflammatory
disease
Prior art date
Application number
ZA200206252A
Inventor
Elizabeth T Keating
James M Kanagy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA200206252B publication Critical patent/ZA200206252B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200206252A 2000-02-08 2002-08-06 Method and compositions for treating an inflammatory disease. ZA200206252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08

Publications (1)

Publication Number Publication Date
ZA200206252B true ZA200206252B (en) 2003-08-26

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206252A ZA200206252B (en) 2000-02-08 2002-08-06 Method and compositions for treating an inflammatory disease.

Country Status (16)

Country Link
EP (1) EP1253919A4 (en)
JP (1) JP2003522142A (en)
KR (1) KR20020073577A (en)
CN (1) CN1398181A (en)
AU (1) AU7205701A (en)
BR (1) BR0108087A (en)
CA (1) CA2398184A1 (en)
CZ (1) CZ20022682A3 (en)
HK (1) HK1051319A1 (en)
HU (1) HUP0300689A3 (en)
IL (1) IL150963A0 (en)
MX (1) MXPA02007688A (en)
NO (1) NO20023737L (en)
PL (1) PL356447A1 (en)
WO (1) WO2001058441A1 (en)
ZA (1) ZA200206252B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
PL210463B1 (en) * 2001-09-19 2012-01-31 Nycomed Gmbh Combination of a nsaid and a pde-4 inhibitor
JP2005515975A (en) * 2001-10-31 2005-06-02 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
US8592400B2 (en) * 2009-02-27 2013-11-26 Boehringer Ingelheim International Gmbh Drug combinations containing PDE4 inhibitors and NSAIDs
JP2012519160A (en) * 2009-02-27 2012-08-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination drug containing PDE4 inhibitor and NSAID
ES2622519T3 (en) 2010-07-14 2017-07-06 Novartis Ag Heterocyclic components of the IP receptor agonist
AR089698A1 (en) 2012-01-13 2014-09-10 Novartis Ag ANTAGONIST HETEROCICLIC COMPOUNDS OF THE IP RECEIVER
JP2016507582A (en) 2013-02-13 2016-03-10 ノバルティス アーゲー IP receptor agonist heterocyclic compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
SK279958B6 (en) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Compounds exhibiting anti-allergic and anti-inflammatory properties, pharmaceutical composition them containing and their use
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (en) * 1996-09-20 1998-10-30 NOVEL N-SUBSTITUTED CYCLIC AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
AU7205701A (en) 2001-08-20
HUP0300689A3 (en) 2003-09-29
PL356447A1 (en) 2004-06-28
EP1253919A1 (en) 2002-11-06
CA2398184A1 (en) 2001-08-16
EP1253919A4 (en) 2007-03-14
CZ20022682A3 (en) 2003-09-17
HUP0300689A2 (en) 2003-07-28
WO2001058441A1 (en) 2001-08-16
JP2003522142A (en) 2003-07-22
CN1398181A (en) 2003-02-19
KR20020073577A (en) 2002-09-27
NO20023737L (en) 2002-09-27
BR0108087A (en) 2002-10-29
NO20023737D0 (en) 2002-08-07
MXPA02007688A (en) 2002-12-13
HK1051319A1 (en) 2003-08-01
IL150963A0 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
ZA200106160B (en) Compositions and methods for treating cataracts.
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU5294100A (en) Method and compositions for treating the inflammatory response
ZA200300418B (en) Method of treating cardiovascular disease.
HK1047288A1 (en) Compositions for treating inflammatory response.
SG101494A1 (en) Exposure method
MX246293B (en) Compositions and methods for treating hyperpigmentation.
GB2370694B (en) Implantation method
ZA200206252B (en) Method and compositions for treating an inflammatory disease.
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
MXPA03004017A (en) Method for the treatment of inflammation.
EP1277459A4 (en) Perming compositions and perming method by using the same
GB0005867D0 (en) Method
GB0123898D0 (en) Method for treating objects
GB0118883D0 (en) Method for treating objects
EP1349548A4 (en) Methods and compositions for treating periodontal disease
EP1261331A4 (en) Method and compositions for treating fibrotic diseases
GB0122810D0 (en) Method for treating objects
GB0123897D0 (en) Method for treating objects
GB0026838D0 (en) Treatment method
GB0024884D0 (en) Method
GB0020910D0 (en) Reduction method
GB0007873D0 (en) Method
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease